Evidence map›Paper›PMID 39746555›Full record

ArticleThe Journal of allergy and clinical immunology2025

Multiomic approaches for endotype discovery in allergy/immunology.

Yeogha Yoon, Supinda Bunyavanich

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of allergy and clinical immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Multi-omics profiling of chronic immune-mediated skin diseases: SKINERGY protocol and strategic evaluation.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
    Observational
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yeogha YoonDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY.
Supinda BunyavanichDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY; Division of Allergy and Immunology, Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: supinda@post.harvard.edu.

Funding

New Horizons in the Prevention and Treatment of Food AllergyUM1AI182034 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Supinda Bunyavanich, SCOTT H SICHERER · 2024 to 2026
$40.5M
Systems Biology of Early Atopy (SUNBEAM) Analysis and Bioinformatics CenterUM1AI173380 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Supinda Bunyavanich · 2023 to 2026
$10.4M
Nasal biomarkers of asthmaR01AI118833 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BUNYAVANICH, SUPINDA · 2015 to 2019
$3.8M
Gut Microbiome Dynamics in Peanut AllergyR01AI147028 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BUNYAVANICH, SUPINDA · 2019 to 2022
$3.3M
NIAID NIH HHS R01 AI118833NIAID NIH HHS R01 AI147028NIAID NIH HHS UM1 AI173380NIAID NIH HHS UM1 AI182034
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

allergyartificial intelligenceasthmaatopic dermatitisendotypeepigenomefood allergygenomemachine learningmetabolomemicrobiomeMultiomicsomicsystems biologytranscriptome

Identifiers

PMID39746555
PMCPMC12513499

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.